NAD+ Peptides Guide: NMN, NR, NADH & Mitochondrial Anti-Aging Protocols

NAD+ (nicotinamide adenine dinucleotide) occupies a unique position in the longevity and peptide therapy world. While NAD+ itself is not technically a peptide, it is so frequently discussed alongside peptide therapy, and its precursors are so commonly included in peptide protocols, that a thorough understanding is essential for anyone exploring comprehensive anti-aging or performance optimization.

This guide covers the NAD+ ecosystem: the molecule itself, its precursors (NMN, NR), the reduced form NADH, how they relate to peptide protocols, the science of mitochondrial function, and practical dosing guidance.

Understanding NAD+ and Its Role

NAD+ is a coenzyme found in every living cell. It is essential for:

• Energy metabolism: NAD+ is a critical electron carrier in the mitochondrial electron transport chain (ETC), accepting electrons during glycolysis and the citric acid cycle to generate ATP — cellular energy
• Sirtuin activation: NAD+ is a required substrate for sirtuins (SIRT1-7), the longevity-associated deacetylase enzymes. Sirtuins regulate gene expression, DNA repair, metabolic adaptation, and stress resistance
• PARP enzyme function: PARPs (poly-ADP ribose polymerases) require NAD+ for DNA repair. Severe DNA damage depletes NAD+ as PARPs consume it
• CD38 activity: CD38, an NAD+-consuming enzyme, increases with aging and inflammation, contributing to age-related NAD+ decline

The NAD+ Decline Problem

NAD+ levels drop by approximately 50% between age 20 and 60. This decline is associated with:

• Reduced mitochondrial efficiency and energy production
• Impaired DNA repair capacity
• Reduced sirtuin activity (epigenetic aging)
• Increased cellular senescence
• Metabolic dysfunction

Restoring NAD+ levels in aging tissues has become one of the central strategies in geroscience.

NAD+ Precursors: NMN vs. NR

Rather than administering NAD+ directly (it is poorly absorbed when taken orally), practitioners use NAD+ precursors that are efficiently converted to NAD+ intracellularly.

Nicotinamide Mononucleotide (NMN)

NMN is a direct precursor to NAD+ — one enzymatic step (NMN adenylyltransferase) converts NMN to NAD+. Research by Dr. Shin-ichiro Imai at Washington University has shown remarkable results in aged mice: NMN supplementation restored NAD+ levels, improved muscle function, energy metabolism, eye function, and even extended lifespan in some models.

Key human NMN studies:

• A 2021 Japanese study (Imai et al.) found oral NMN (250 mg/day) significantly increased blood NAD+ levels in healthy middle-aged and older adults
• A 2022 study in runners showed NMN improved aerobic capacity and muscle oxygen utilization
• A Washington University trial found NMN improved insulin sensitivity in women with prediabetes

Dosing:

• Research doses: 250–500 mg/day
• Some protocols use higher doses (750–1,000 mg/day) for more aggressive NAD+ restoration
• Sublingual or IV forms have higher bioavailability than standard oral capsules
• Timing: Morning, as NAD+ levels are lowest after overnight metabolism

Nicotinamide Riboside (NR)

NR (marketed as Niagen by ChromaDex) is another NAD+ precursor, requiring two enzymatic steps to reach NAD+: NR → NMN → NAD+. Multiple human clinical trials have been completed with NR.

NR human evidence:

• Multiple trials confirm NR significantly raises blood NAD+ levels
• Studies in older adults, obese individuals, and heart failure patients show improved metabolic markers, reduced inflammation, and in some cases improved cardiac function
• The Elysium BASIS product (NR + pterostilbene) has been studied in a company-sponsored trial showing DNA methylation improvements (epigenetic aging marker)

Dosing:

• Clinical trials: 250–1,000 mg/day
• Most commonly used dose: 300–500 mg/day
• Generally taken in the morning

NMN vs. NR: What's the Difference?

Both raise NAD+ effectively. Key differences:

| Feature | NMN | NR | |---------|-----|-----| | Steps to NAD+ | 1 | 2 | | Transporter | SLC12A8 (intestinal NMN transporter) | Equilibrative nucleoside transporters | | Cost | Higher | Moderate | | Human trials | Growing | More established | | Patent status | Multiple competing | ChromaDex key patent holder |

The "best" choice remains debated. Many longevity practitioners recommend either or rotate between them.

NADH: The Reduced Form

NADH is the reduced form of NAD+ — it carries the hydrogen (electron) that NAD+ accepts during metabolism and delivers it to the electron transport chain. NADH supplementation has been studied for energy, cognitive function, and neurological conditions.

NADH is available as oral supplements (ENADA is the most studied brand). In double-blind trials, NADH showed benefits for:

• Chronic fatigue syndrome (CFS/ME)
• Parkinson's disease (through NADH's role in dopamine synthesis)
• Cognitive function in older adults

However, NADH is more stable when taken sublingually or in enteric-coated formulations, as it can be oxidized in the GI tract.

IV NAD+ Infusions

Intravenous NAD+ delivery bypasses absorption limitations entirely and delivers NAD+ directly to circulation for immediate cellular uptake. IV NAD+ infusions (typically 500–1,000 mg over 4–8 hours) have become popular in longevity clinics and addiction treatment settings.

Clinical applications of IV NAD+:

• Addiction and alcohol withdrawal (research by Dr. William Hitt and colleagues)
• Neurological recovery (TBI, post-stroke)
• Anti-aging and metabolic optimization
• Psychiatric conditions (depression, PTSD — anecdotal and early research)

IV NAD+ infusions produce a characteristic flush, chest tightness, and nausea during administration that resolves when the infusion rate is slowed. These are not dangerous but require rate management.

NAD+ in Peptide Protocols

NAD+ precursors are frequently included in comprehensive peptide protocols because:

1. Mitochondrial synergy: Peptides that support GH/IGF-1 (like Sermorelin or GHRP-6) increase metabolic demands on cells; NAD+ supports the mitochondrial capacity to meet those demands
2. Sirtuin activation: Combined NAD+ restoration + sirtuin activation creates conditions for optimal cellular maintenance and longevity signaling
3. Recovery enhancement: Improved NAD+/NADH ratio accelerates cellular repair, complementing peptides like BPC-157 that promote tissue regeneration
4. DNA repair: PARP-mediated DNA repair supported by adequate NAD+ reduces genomic instability — important when running peptides that increase cellular activity

A common combination protocol includes NMN or NR alongside resveratrol (sirtuin activator), with peptide therapy layered on top for tissue-specific benefits.

Side Effects and Safety

NAD+ precursors are generally very well tolerated:

• NMN: Minimal side effects at recommended doses. Some report mild nausea at higher doses (>1,000 mg). Theoretical concern about NAD+ raising CD38 (which consumes NAD+) has been raised but not confirmed clinically.
• NR: Generally well tolerated. Mild flushing at higher doses (less than niacin). Some reports of mild GI upset.
• NADH: Oral forms well tolerated. IV NADH can cause similar flush/nausea to IV NAD+.

Long-term safety of very high doses remains under study. There is a theoretical concern about high NAD+ levels potentially supporting cancer cell metabolism (Warburg effect), but this has not been demonstrated as clinically significant at supplemental doses.

Frequently Asked Questions

Q: Is NMN or NR better for raising NAD+? Both work well. NMN has a more direct conversion pathway and recent human trials suggest robust NAD+ elevation. NR has a longer track record in human trials. Many practitioners use whichever form their patient tolerates best or alternate between them.

Q: How long does it take to feel the effects of NMN or NR? Most people notice improved energy, mental clarity, and exercise recovery within 2–4 weeks. Objective metabolic improvements (insulin sensitivity, lipid markers) take 1–3 months to measure.

Q: Should I take NAD+ precursors with my peptide protocol? Many longevity and peptide practitioners include NAD+ precursors as a foundational part of their protocols. The combination of GH optimization (via peptides) + mitochondrial support (via NAD+) + sirtuin activation (via resveratrol/fisetin) represents a multi-layered approach to biological aging.

Q: Are IV NAD+ infusions better than oral NMN or NR? IV NAD+ bypasses absorption and delivers NAD+ directly to the bloodstream, producing more immediate cellular uptake. For acute applications (recovery, addiction, neurological support), IV has advantages. For chronic anti-aging supplementation, high-quality oral NMN or NR is practical and effective.

Q: Can children or young adults benefit from NAD+ supplementation? NAD+ levels are naturally higher in youth. Young, healthy individuals see less benefit from supplementation than older adults with NAD+ depletion. Some athletes use NMN for performance benefits, which is supported by emerging research, but it is not primarily an anti-aging intervention for those under 35.